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Abstract
Retinal ganglion cells (RGCs) are the sole projecting neurons of the
retina and their axons form the optic nerve. Here, we show that
embryogenesis-associated mouse RGC differentiation depends on
mitophagy, the programmed autophagic clearance of mitochon-
dria. The elimination of mitochondria during RGC differentiation
was coupled to a metabolic shift with increased lactate production
and elevated expression of glycolytic enzymes at the mRNA level.
Pharmacological and genetic inhibition of either mitophagy or
glycolysis consistently inhibited RGC differentiation. Local hypoxia
triggered expression of the mitophagy regulator BCL2/adenovirus
E1B 19-kDa-interacting protein 3-like (BNIP3L, best known as NIX)
at peak RGC differentiation. Retinas from NIX-deficient mice
displayed increased mitochondrial mass, reduced expression of
glycolytic enzymes and decreased neuronal differentiation.
Similarly, we provide evidence that NIX-dependent mitophagy
contributes to mitochondrial elimination during macrophage
polarization towards the proinflammatory and more glycolytic M1
phenotype, but not to M2 macrophage differentiation, which
primarily relies on oxidative phosphorylation. In summary, devel-
opmentally controlled mitophagy promotes a metabolic switch
towards glycolysis, which in turn contributes to cellular differenti-
ation in several distinct developmental contexts.
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Introduction
Autophagy is a catabolic pathway that mediates the degradation and
recycling of intracellular components, including whole organelles,
to sustain cell homeostasis (Boya et al, 2013). Autophagy is the sole
mechanism that allows for the degradation of entire mitochondria, a
process commonly known as mitophagy. While mitophagy primar-
ily eliminates damaged or dysfunctional mitochondria (Ashrafi &
Schwarz, 2013), this pathway can also mediate the degradation
of mitochondria in developmental contexts, a process known as
programmed mitophagy (Ney, 2015). BCL2/adenovirus E1B
19-kDa-interacting protein 3-like (BNIP3L), also known as NIX, is
an essential regulator of programmed mitophagy during reticulocyte
maturation (Aerbajinai et al, 2003; Diwan et al, 2007; Schweers
et al, 2007; Sandoval et al, 2008). During programmed mitophagy,
NIX is mainly regulated at the transcriptional level and acts as
a mitophagy receptor, mediating autophagic sequestration of mito-
chondria by interacting with LC3 via its LIR domain (Novak et al,
2010).
Metabolic reprogramming is a process by which cells shift their
metabolism from oxidative phosphorylation towards glycolysis and
convert glucose into lactate even in the presence of oxygen. This
phenomenon was first described in cancer cells, but has since been
observed in other cell types, including embryonic stem cells, proin-
flammatory M1 macrophages and cells of the adult retina, and it is
thought to be essential to fulfill the metabolic requirements of those
cells (Galvan-Pena & O’Neill, 2014; Ng et al, 2015; Chandel et al,
2016). Hypoxia also triggers metabolic shift towards glycolysis. This
type of metabolism is also observed in stem cells and is thought to
constitute an adaptation to the hypoxic conditions present in vivo
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during development, in adult stem cell niches and in the inflamed
tissue (Suda et al, 2011; Escribese et al, 2012). Interestingly,
hypoxia is a strong inductor of mitophagy (Zhang et al, 2008).
How the complex functionality of the nervous system arises
from a pool of undifferentiated neuroepithelial cells is one of the
more fascinating aspects of embryonic development (Valenciano
et al, 2008). These neuroepithelial cells undergo marked changes
to generate differentiated neurons and glial cells. Cell prolifera-
tion requires nutrients, energy and biosynthetic activity to dupli-
cate all macromolecular components during each passage of the
cell cycle. Differentiation requires profound changes in cellular
components and a shift in metabolic activity. Indeed, metabolic
pathways may be controlled by the same signals that control cell
differentiation (Agathocleous & Harris, 2013). The retina, a
model organ for the study of the central nervous system, is a
three-layered structure composed of one glial and six distinct
neuronal cell types, which arise from a pool of multipotent reti-
nal progenitor cells (Stenkamp, 2015). In mice, retinal neurogen-
esis is an orderly process that starts with the differentiation of
retinal ganglion cells (RGCs) and is followed by that of other
neuronal cell types. During retinal development, cell differentia-
tion follows a central-to-peripheral gradient, with the result that
the central retina is more developmentally advanced than the
peripheral retina (Stenkamp, 2015).
We have previously shown that autophagy genes are essential
for the generation of mature neurons from olfactory bulb neural
stem cells (Vazquez et al, 2012). Moreover, blockade of autophagy
in the embryonic chick retina results in decreased ATP levels and
hampers the elimination of apoptotic cells generated during neuro-
genesis (Melle´n et al, 2008, 2009). Interestingly, both these pheno-
types are restored by supplying pyruvate as a cell-permeable
precursor (methyl pyruvate), suggesting a connection between
autophagy and cell metabolism during neuronal differentiation
(Boya et al, 2016). Moreover, cancer cells engage mitophagy to
promote metabolic reprogramming towards glycolysis during
prolonged mitotic arrest (Domenech et al, 2015). Here, we show
that NIX- and Atg5-dependent mitophagy mediates a metabolic shift
towards glycolysis that allows RGC generation in the embryonic
mouse retina. Furthermore, we describe a mitophagy-dependent
metabolic shift that occurs during the polarization of macrophages
towards a proinflammatory and more glycolytic M1 phenotype.
Taken together, our data show that programmed mitophagy triggers
metabolic reprogramming towards glycolysis during cellular
differentiation.
Results
Mitochondrial rarefaction during embryonic RGC differentiation
In the mouse retina, neurogenesis starts around day E12.5 with
the differentiation of RGCs, the first neurons to be generated. As
expected, immunofluorescence analyses revealed the presence of
the RGC-specific transcription factor Brn3a and c-synuclein (an-
other RGC marker) from E13.5, with levels peaking at E15.5 in
the RGC layer of mouse retinal flatmounts (Fig 1A and B, and
Appendix Figs S1 and S2). In the same retinas, immunostaining
for the mitochondrial protein TOMM20 decreased after E13.5
(Fig 1C and D, insets below, and Appendix Fig S1C). This
decrease in the number of mitochondria during retinal embryonic
development was corroborated by labelling dissociated retinas at
different embryonic stages with the mitochondrion-specific dye
MitoTracker Deep Red (MTDR), which was quantified by flow
cytometry (Fig 1E and F). This decrease in mitochondrial
number could not be attributed to decreased expression of genes
involved in mitochondrial biogenesis, such as Ppargc1a and
Tfam, as their expression remained unchanged during the
embryonic stages assessed (Fig EV1A). Moreover, electron micro-
scopy analyses revealed that at E15.5 the number of mitochon-
dria in each RGC was reduced as compared with that of
proliferating neuroblasts (Fig 1G and H). Mitochondria from
neuroblasts (Nbs) were large and displayed well-organized
cristae, indicative of a high metabolic rate, while those from
RGCs were comparatively smaller and contained fewer cristae
(Fig 1I). Together these data suggest that programmed elimina-
tion of mitochondria occurs during RGC development.
Mitophagy-mediated elimination of mitochondria during
RGC development
Since autophagy is the only known catabolic pathway capable of
mediating the degradation of entire mitochondria, we analysed
autophagic activity during embryonic development in the mouse
retina. The autophagy-associated lipidation of microtubule-asso-
ciated proteins 1A/1B light chain 3 (MAP1LC3, better known as
LC3), which gives rise to an increase in the electrophoretic mobility
of LC3 (LC3-II), was increased during retinal development (Fig 1J).
Consistently, incubation of retinal explants for 3 h with the lysoso-
mal inhibitor hydroxychloroquine (HCQ) further increased LC3-II
accumulation, indicating that basal autophagic flux is enhanced
during the early stages of development of the embryonic mouse
retina (Fig 1J). Transmission electron microscopy revealed the pres-
ence of mitochondria inside autophagosomes in RGCs at E15.5 in
these conditions (Fig 1K) and the number of mitochondria was
increased after inhibition of lysosomal degradation (Fig 1L),
suggesting that the decrease in mitochondrial mass during retinal
development is mediated by autophagy.
Next, we incubated retinas at different embryonic stages with
the general autophagy inhibitor 3-methyladenine (3-MA) or with
cyclosporine A (CsA), an inhibitor of mitochondrial cyclophilin
D that suppresses mitophagy in many different cell types and
experimental conditions (Kim et al, 2007; Carreira et al, 2010;
Domenech et al, 2015; Mauro-Lizcano et al, 2015). Inhibition of
either autophagy or mitophagy for 6 h prevented the decrease in
TOMM20 labelling (Figs 2A and B, and EV1B) and resulted in
increased MTDR staining, as measured by flow cytometry
(Fig 2C and D). Corroborating these results, immunofluorescence
and immunoblot analyses revealed increased expression of the
mitochondria respiratory chain component COX-IV (Fig EV1C and
D). Incubation of E15.5 retinas with a combination of 3-MA and
CsA failed to further increase mitochondrial number compared
with either compound alone, suggesting that both inhibitors act
on the same signalling pathway (Fig EV1E). Together, these
results indicate that the autophagy-dependent elimination of
mitochondria during retinal development occurs specifically at
E15.5.
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Figure 1. Mitochondrial mass decreases during embryonic retinal development.
A Immunostaining of the retinal ganglion cell (RCG)-specific transcription factor Brn3a (cyan) in the RGC layer of mouse retinal flatmounts at the indicated
embryonic days (E). The maximal projection in the RGC layer is shown. Scale bar, 50 lm.
B Quantification of RGC density per mm2 at the indicated embryonic stages in retinas stained as in (A) (n = 6 per group). Data are presented as mean  SEM.
***P < 0.001 (Mann-Whitney U-test).
C Immunostaining with the mitochondrial marker TOMM20 (red) in the RGC layer of the same retinas as in (A). Scale bar, 50 lm. Insets show TOMM20 staining (red)
and nuclei labelled with DAPI (blue) in a confocal plane in the indicated region. Scale bar, 20 lm.
D TOMM20-positive pixel staining at the indicated embryonic stages labelled as in (C) (n = 6 per group). Data are presented as mean  SEM. ***P < 0.001 (Mann-
Whitney U-test).
E, F Flow cytometry histograms and percentage mean fluorescence intensity (% MitoTracker) in dissociated retinas, corresponding to different embryonic stages, stained
with MitoTracker Deep Red (MTDR) (n = 5–12 retinas per group). Data are presented as mean  SEM. **P < 0.01, ***P < 0.001 (Mann-Whitney U-test).
G Ultrastructural analysis of neuroblast (Nb) and RGC from an E15.5 mouse retina. Scale bar, 1 lm. Arrows indicate mitochondria.
H Quantification of the number of mitochondria per cell in G (n = 12–14 cells per group). Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney U-test).
I Mitochondrial morphology (m) in retinal Nb and RGC at E15.5. Scale bars, 500 nm.
J Immunoblot of retinas at different embryonic stages incubated for 3 h in the absence () or presence (+) of hydroxychloroquine to block autophagic flux.
K Autophagosomal membrane (AP) surrounding a mitochondrion (arrows in left-hand image) in an E15.5 mouse retina in the presence of HCQ to block lysosomal
degradation. Scale bar, 500 nm. Insets of the indicated areas show four adjacent membranes (right).
L Increase in the number of mitochondrial per nm2 in RGCs from E15.5 mouse retinas in the presence of HCQ (n = 12 per group). Data are presented as mean  SEM.
***P < 0.001 (Mann-Whitney U-test).
Source data are available online for this figure.
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Mitophagy-dependent metabolic reprogramming in
retinal development
Our previous findings in cell lines suggest that high levels of mito-
phagy may result in a shift from an oxidative to a glycolytic meta-
bolic profile (Domenech et al, 2015). We next used mass
spectrometry to measure the levels of selected metabolites during
mouse retinal development. Levels of glycolytic metabolites, includ-
ing lactate, increased from E15.5, but subsequently decreased at
birth (Fig 2E). In agreement, cellular metabolic analyses using
Seahorse technology revealed that the extracellular acidification rate
(ECAR), which is an indirect measurement of glycolysis, increased
at E15.5, but decreased at later developmental stages (Fig 2F). This
increase in ECAR was prevented by incubation for 6 h with 3-MA or
CsA (Fig 2G). As expected, mitochondrial respiration decreased
at E15.5 and increased in retinas treated with 3-MA or CsA
(Appendix Fig S3A and B). RNA transcriptome analyses showed a
dramatic increase in mRNA expression of multiple genes encoding
glycolytic enzymes (Hk2, Pfkfb3 and Gapdh) and glucose trans-
porters (Scla2a1 and Scla2a3) beginning at E15.5 (Fig 2H). Interest-
ingly, treatment of E15.5 retinal explants with 3-MA or CsA
significantly reduced mRNA expression of these enzymes, implicat-
ing mitophagy in the metabolic shift towards glycolysis during
embryonic retinal development (Fig 2I).
Mitophagy-dependent metabolic reprogramming and
differentiation of macrophages
We next investigated whether mitophagy could also play a critical
role in other differentiation pathways associated with increased
glycolysis. Metabolic reprogramming towards glycolysis has been
well described during M1 macrophage activation (O’Neill & Pearce,
2016). Macrophages can be broadly classified into two groups. M1
macrophages, generated in response to proinflammatory conditions
such as TLR agonists in combination with IFN-c, play important
roles in the elimination of bacterial infections and are considered
more inflammatory (O’Neill & Pearce, 2016). IL-4-activated (M2)
macrophages participate in tissue repair and have anti-inflammatory
properties (O’Neill & Pearce, 2016). M1 and M2 macrophages also
differ in their metabolic signatures. M1 macrophages display a
glycolytic profile, characterized by increased expression of several
glycolytic regulators and enhanced lactate production, while M2
macrophages show high levels of oxidative phosphorylation
(Rodriguez-Prados et al, 2010; Izquierdo et al, 2015; Jha et al,
2015). Crucially, macrophages can be reprogrammed by targeting
their metabolism (Izquierdo et al, 2015; Mills & O’Neill, 2016). To
explore the potential role of mitophagy in M1 macrophage polariza-
tion, we induced the differentiation of peritoneal macrophages into
either the M1 or M2 phenotype by incubation with LPS/INF-c and
IL-4/IL-13, respectively (Fig EV2A). M1 macrophages showed
decreased MTDR staining as compared with M2 macrophages, indi-
cating a reduction in mitochondrial mass (Fig EV2B). MTDR levels
dramatically increased when M1, but not M2, macrophages were
cultured in the presence of 3-MA or CsA (Fig EV2C and D). 3-MA
and CsA treatment altered cell morphology from the round shape
characteristic of the M1 phenotype to the more elongated shape
associated with the M2 activation state (Fig EV2E and F). Moreover,
mRNA expression of M1 markers such as Tnf, Nos2 and Il1b, as well
as expression of several glycolytic enzymes, was reduced when M1
macrophages were incubated in the presence of autophagy or mito-
phagy inhibitors (Fig EV2G). Together, these data indicate that
mitophagy regulates the glycolytic shift associated with cellular
differentiation in several cell types.
Autophagy-dependent metabolic reprogramming regulates
RGC differentiation
We next investigated whether mitophagy and the concomitant meta-
bolic shift observed during retinal development are implicated in
the neuronal differentiation of RGCs. Inhibition of autophagy or
mitophagy with CsA or 3-MA resulted in a decrease in the number
of cells positive for the RGC-specific transcription factor Brn3a at
E15.5 (Fig 3A and C). Moreover, blockade of autophagy and mito-
phagy resulted in alterations in axonal morphology as determined
by b-III-tubulin labelling in retinal flatmounts (Fig 3B and D), in line
with the view that inhibition of autophagy and mitophagy attenu-
ates RGC differentiation. Next, we investigated whether experimen-
tal induction of autophagy stimulates RGC differentiation. In the
developing retina, neurogenesis follows a central-to-peripheral
gradient, meaning that the first RGCs are generated close to the optic
nerve at E13.5 (Appendix Fig S1A and B). Pharmacological induc-
tion of autophagy with rapamycin at E13.5 increased the number of
◀ Figure 2. A mitophagy-dependent metabolic shift towards glycolysis occurs during embryonic retinal development.A Mitochondrial labelling by TOMM20 immunostaining in flat-mounted retinas (E15.5) incubated for 6 h in the presence of 5 lM CsA or 10 mM 3-MA. TOMM20
immunostaining is shown in red and DAPI-stained nuclei in blue. A single confocal plane is shown and corresponds to the inset from the lower magnification
images displayed in Fig EV1B. Scale bar, 20 lm.
B Quantification of TOMM20 immunostaining in retinas cultured as in (A) at the indicated embryonic stages (n = 4–16 retinas per group). Data are presented as
mean  SEM. *P < 0.05, **P < 0.01 (Mann-Whitney U-test).
C, D Quantification of the percentage mean fluorescence intensity (% MitoTracker) and representative flow cytometry histograms at the indicated embryonic stages in
retinal explants cultured as in (A) and stained with MTDR (n = 6–57 retinas per group). Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney U-test and
Student’s t-test).
E Heat map indicating expression of glycolysis-related metabolites in mouse retinas at different developmental stages. P0, Postnatal day 0.
F, G Extracellular acidification rate (ECAR) in embryonic retinas at the indicated developmental stages (F) (n = 19–49 pools of retinas per group) and in E15.5 retinas
incubated for 6 h in the presence of 3-MA or CsA (G) (n = 15–19 pools of two retinas per group). Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney
U-test (F) and Student’s t-test (G)).
H Heat map showing the relative mRNA expression of glycolysis regulators as determined by transcriptomic analyses in mouse retinas at the indicated
developmental stages.
I mRNA expression of glycolysis regulators in E15.5 retinas incubated for 6 h with 3-MA or CsA (n = 3 pools of two retinas per group). Data are presented as
mean  SEM. *P < 0.05, **P < 0.01 (Mann-Whitney U-test).
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Figure 3. Retinal ganglion cell (RGC) differentiation is regulated by autophagy-dependent mitochondrial degradation.
A–D (A) Assessment of RGC differentiation by Brn3a immunostaining in E15.5 retinas incubated for 6 h with 10 mM 3-MA or 5 lM CsA. Maximal projection is displayed.
Scale bar, 50 lm. (B) b-III-tubulin immunostaining of RGC axons in retinal flatmounts from E15.5 retinas incubated for 6 h with 10 mM 3-MA or 5 lM CsA.
Maximal projection is displayed. Scale bar, 50 lm. Magnified images of boxed regions are shown in (D). (C) Quantification of the number of RGCs in E15.5 retinas
incubated as in (A) (n = 8–12 retinas per group). Data are presented as mean  SEM. *P < 0.05, **P < 0.01 (Mann-Whitney U-test).
E Assessment of RGC differentiation by Brn3a immunostaining in retinal flatmounts from E13.5 retinas incubated with 200 nM rapamycin in the absence or presence
of 3-MA or CsA. Scale bar, 50 lm. Asterisks indicate the optic nerve.
F TOMM20 immunostaining in E13.5 retinas incubated as in (E). Scale bar, 20 lm.
G Quantification of the number of RGCs in retinas cultured as in (E) (n = 5–18 retinas per group). Data are presented as mean  SEM. *P < 0.05, **P < 0.01 (Mann-
Whitney U-test).
H Quantification of TOMM20 immunostaining in E13.5 retinas incubated as in (F) (n = 9–22 per group). Data are presented as mean  SEM. *P < 0.05, ***P < 0.001
(Mann-Whitney U-test).
I, J (I) Percentage mean fluorescence intensity (% MitoTracker) in E13.5 retinas incubated for 6 h with rapamycin in the absence or presence of 3-MA, and a
representative flow cytometry histogram (J) (n = 8–23 retinas per group). Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney U-test).
K, L (K) Percentage mean fluorescence intensity (% MitoTracker) in E13.5 retinas incubated for 6 h with rapamycin in the absence or presence of CsA, and a
representative flow cytometry histogram (L) (n = 8–23 retinas per group). Data are presented as mean  SEM. *P < 0.05, **P < 0.01 (Mann-Whitney U-test).
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differentiated RGCs in this area (Fig 3E and G) and simultaneously
resulted in decreased mitochondrial density, as determined by
immunofluorescence (Fig 3F and H) and flow cytometry (Fig 3I–L).
All these effects were prevented by simultaneous addition of CsA or
3-MA, indicating that they involved autophagy-dependent mito-
phagy (Fig 3E–L). These findings suggest that RGC differentiation is
regulated by autophagy-dependent mitochondrial degradation.
In support of this interpretation, immunofluorescence revealed
more TOMM20-positive structures in retinas isolated from Atg5-
deficient mice versus autophagy-competent wild-type controls (Fig 4A
and B, and Appendix Fig S4A). Interestingly, at E13.5 this increase
was observed only in the central and more mature area of the retina,
where young RGCs (Y) are located (see Appendix Fig S1A and B);
no differences were observed between wild-type and autophagy-
deficient retinas in the area in which the neuroblasts (Nbs) are
located (Fig 4C). Similarly, pharmacological inhibition of autophagy
and mitophagy increased mitochondrial number in young RGCs, but
not in neuroblasts (Appendix Fig S4C). Conversely, MTDR staining
throughout the entire retina revealed no differences in mitochondrial
mass at E13.5 between wt and autophagy-deficient retinas. This can
be explained by the facts that flow cytometry is performed in all
retinal cells, and young RGCs only account for a small percentage of
the total number of cells in the retina at this early stage of differentia-
tion (Fig 4D). At E15.5 and E18.5, Atg5-deficient retinas exhibited an
increase in MTDR staining, as detected by flow cytometry (Fig 4D).
Incubation of E15.5 Atg5-deficient retinas with 3-MA or CsA did not
further increase MTDR staining, suggesting that pharmacological and
genetic inhibition of autophagy gives rise to comparable phenotypic
effects (Appendix Fig S4D and E). Analysis of autophagy-deficient
retinas revealed increased TOMM20 immunofluorescence at E15.5 in
retinal sections (Fig 4E) and increased COX-IV levels in flatmounts
(Appendix Fig S4B).
Of note, Atg5-deficient retinas showed reduced mRNA expression
of several regulators of glycolysis with respect to wild-type retinas
(Fig 4F), as well as decreased lactate production as determined by
ECAR (Fig 4G), in line with the deficient metabolic reprogramming
towards glycolysis observed following pharmacological inhibition
of autophagy or mitophagy during retinal development. Expression
of the RGC-specific transcription factor Brn3a was reduced in
Atg5-deficient retinal flatmounts as compared with controls (Fig 4H
and I) and in retinal sections stained with Brn3a and c-synuclein
(Fig EV3). Finally, in autophagy-deficient animals staining for
neuronal-specific b-III-tubulin was decreased in retinal sections
and revealed axonal alterations (Fig 4J and K). Together these data
indicate an increase in mitochondrial mass, attenuation of the
glycolytic shift and altered neuronal differentiation in Atg5-deficient
retinas.
Hypoxia triggers mitophagy-dependent metabolic
reprogramming in RGC differentiation
Metabolic reprogramming towards glycolysis reduces oxygen
consumption and is a classical response to tissue hypoxia. We thus
investigated whether hypoxia occurred during mouse embryonic
retinal development using the Hypoxyprobe method, which detects
adducts formed between pimonidazole and proteins in conditions of
low oxygen tension and has been previously used to assess hypoxic
areas during embryonic development (Lee et al, 2001). We detected
an elevated formation of pimonidazole adducts in the embryonic
mouse retina, which were greatly reduced in the adult tissue with a
faint staining in some RGCs (Fig 5A). More importantly, staining for
pimonidazole adducts was observed in the somas of young RGCs as
they were still migrating (Fig 5A). Staining for GLUT1 (encoded by
SLC2A1, a HIF-1 target gene) was increased at E15.5 and E18.5, con-
firming the transcriptomic data and further suggesting that hypoxia-
dependent metabolic reprogramming occurs at these developmental
stages. Indeed, the expression of multiple HIF-1 target genes was
upregulated in embryonic mouse retinas between E15.5 and E18.5,
subsequently decreasing at birth (Fig 5B). Together these data
demonstrate the existence of tissue hypoxia during mouse embry-
onic retinal development and an increase in the expression of multi-
ple HIF-1 alpha-responsive genes.
To evaluate the relationship between hypoxia and mitophagy
during RGC differentiation, E13.5 and E15.5 retinas were cultured
▸Figure 4. Genetic inhibition of autophagy impairs RGC differentiation.A TOMM20 immunostaining in wild-type (Atg5+/+) and Atg5-deficient (Atg5/) retinal whole mounts corresponding to the indicated embryonic stages. At E13.5, the
central retina is shown where the young RGCs are located. Scale bar, 10 lm.
B Quantification of TOMM20 immunostaining in retinas from (A) (n = 4–15 retinas per group). Data are presented as mean  SEM. *P < 0.05, ***P < 0.001 (Mann-
Whitney U-test).
C Quantification of TOMM20 immunostaining in peripheral (Nb) and central (young RGCs) areas of wild-type (Atg5+/+) and Atg5-deficient (Atg5/) retinas at E13.5
(n = 4–15 retinas per group). Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney U-test).
D Flow cytometry histograms and mean fluorescence intensity in dissociated retinas, stained with MTDR, corresponding to different embryonic stages, and
corresponding quantification (n = 7–16 retinas per group). Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney U-test).
E TOMM20 immunostaining in E15.5 retinal sections from wild-type (Atg5+/+) and Atg5-deficient (Atg5/) retinas. NbL, neuroblast layer; RGCL, retinal ganglion cell
layer. Scale bar, 75 lm.
F mRNA expression of the indicated genes in wild-type (Atg5+/+) and Atg5-deficient (Atg5/) retinas at E15.5 (n = 5–6 pools of two retinas per group). Data are
presented as mean  SEM. *P < 0.05, **P < 0.01 (Mann-Whitney U-test).
G Extracellular acidification rate (ECAR) in wild-type (Atg5+/+) and Atg5-deficient (Atg5/) at E15.5 (n = 11–15 pools of two retinas per group). Data are presented as
mean  SEM. *P < 0.05 (Mann-Whitney U-test).
H Quantification of the number of RGCs in (I) (n = 11–12 retinas per group). Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney U-test).
I Assessment of RGC differentiation by Brn3a immunostaining in retinal flatmounts from wild-type (Atg5+/+) and Atg5-deficient (Atg5/) mouse retinas at E15.5. Scale
bar, 50 lm.
J b-III-tubulin immunostaining (green) of RGCs in retinal sections from E15.5 Atg5-deficient mice. DAPI-stained nuclei are shown in blue. Scale bar, 75 lm. Higher
magnification images of the RGCL are shown on the right. Scale bar, 20 lm.
K b-III-tubulin immunostaining of RGCs axons in retinal flatmounts from E13.5 and E15.5 retinas from wild-type (Atg5+/+) and Atg5-deficient (Atg5/) animals. Scale
bar, 50 lm.
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Figure 5. Hypoxia regulates mitophagy during retinal development.
A Immunostaining for pimonidazole (red), b-III-tubulin (green, upper row) and SLC2A1 (green, bottom row) in mouse eye sections at the indicated stages. NbL,
neuroblast layer; RGCL, retinal ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer. Scale bar, 50 lm.
B Heat map showing the relative mRNA expression of HIF-1 alpha target genes as determined by transcriptomic analyses in mouse retinas at the indicated
developmental stages.
C, D TOMM20 immunostaining and corresponding quantification in retinal flatmounts corresponding to E13.5 and E15.5 retinas incubated with the hypoxia inducer
DFO (1 mM) in the absence or presence of CsA or 3-MA (n = 3–8 retinas per group). Scale bar, 10 lm. Y (young) indicates the peripheral area of the E15.5 retina
containing less mature RGCs, and M (mature) indicates the centre of the retina, containing more mature RGCs. Data are presented as mean  SEM. *P < 0.05,
**P < 0.01 (Mann-Whitney U-test).
E mRNA expression of the indicated genes in E15.5 retinas treated as in C (n = 3–8 pools of two retinas per group). Data are presented as mean  SEM. *P < 0.05,
**P < 0.01 (Mann-Whitney U-test).
F Quantification of RGC number after Brn3a immunostaining in retinas treated as in (C) (n = 3–9 per group). Data are presented as mean  SEM. *P < 0.05,
**P < 0.01 (Mann-Whitney U-test).
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with deferoxamine (DFO), an iron chelator that inhibits prolyl
hydroxylases leading to HIF-1 alpha stabilization (Safran & Kaelin,
2003). DFO induced marked TOMM20 degradation (Fig 5C and D),
decreased MTDR staining (Fig EV4A), increased mRNA expression
of glycolytic genes (Fig 5E) and stimulated RGC differentiation as
determined by Brn3a immunostaining (Figs 5F and EV4B). More
importantly, all these DFO-induced effects were completely blocked
by CsA or 3-MA (Figs 5C–F, and EV4A and B), suggesting that they
are mitophagy dependent. Furthermore, DFO treatment of Atg5-
deficient retinas had no additional effect on mitochondrial mass or
RGC differentiation, supporting the view that the hypoxia occurs
upstream of mitophagy (Appendix Fig S5). Finally, DFO treatment
resulted in a decrease in mitochondrial membrane potential that
was not affected by mitophagy inhibition, suggesting that this mito-
chondrial alteration occurs upstream, and perhaps as a trigger
of mitophagy (Fig EV4C). Next, we investigated whether these
phenomena were also observed in vivo during retinal development.
In agreement with our ex vivo data, mitochondrial membrane poten-
tial was reduced during retinal development (Fig EV4D). Altogether
these findings indicate that hypoxia-induced mitophagy regulates
RGC differentiation during retinal development.
Obligatory contribution of NIX to mitophagy and
RGC differentiation
Among HIF-1-responsive genes, expression of the mitophagy regula-
tor BNIP3L (NIX) increased rapidly at E15.5 (Figs 5B and 6A). This
suggests that NIX upregulation may constitute the molecular link
between hypoxia and mitophagy during retinal development. In
support of this hypothesis, retinas from NIX-deficient mice exhibited
increased mitochondrial mass as determined by TOMM20
immunofluorescence in retinal flatmounts (Fig 6B and C) and in
retinal sections (Fig 6D). Moreover, NIX-deficient retinas showed
reduced mRNA expression of several glycolytic genes including
Pfkfb3, Hk2, Gapdh and Pkm2 (Fig 6E), as well as the RGC-specific
transcription factor Brn3a (known as Pou4f1; Fig 6F). These
alterations correlated with a decrease in RGC numbers in retinal
flatmounts and in sections stained with Brn3a and c-synuclein
(Fig 6G–K). Moreover, adult NIX mice displayed increased mito-
chondrial levels and a reduced number of RGCs stained with Brn3a
and c-synuclein (Fig 6L and N). Further supporting the view that
NIX may constitute a molecular link between hypoxia and cell dif-
ferentiation, NIX mRNA expression was upregulated when retinas
were treated with DFO, which recapitulates the observed in vivo
RGC differentiation pathway (Appendix Fig S6A and Fig 5C–F).
Taken together, our results show that during retinal development
activation of NIX-dependent mitophagy at E15.5 regulates metabolic
reprogramming mediating RGC differentiation.
Obligatory contribution of NIX to M1 differentiation
We next investigated whether M1 macrophage polarization was also
NIX dependent. We found that NIX mRNA expression was upregu-
lated in M1 versus M2 macrophages (Fig 6O), in line with the fact
that mitophagy is active in M1 but not M2 macrophages. Interest-
ingly, we observed no differences in mRNA levels of other mito-
phagy regulators between wild-type and NIX-deficient macrophages
(Appendix Fig S6B). Next, we isolated peritoneal macrophages from
wild-type and NIX-deficient mice and directed their differentiation
to either the M1 or M2 phenotype by incubation with LPS/INF-c or
IL-4/IL-13, respectively. In NIX-deficient M1-macrophages, we
observed reduced mRNA expression of Pkm2 and Hk2, which
encode glycolytic enzymes (Fig 6P), and reduced expression of the
proinflammatory cytokine-encoding gene Il1b (Fig 6Q), indicating a
NIX-dependent metabolic shift during M1 macrophage polarization.
No differences in mRNA expression of M1 or M2 markers between
NIX-deficient and wild-type animals were observed in macrophages
differentiated into the M2 macrophages (Appendix Fig S6C and D).
Taken together, these data show that a NIX-dependent metabolic
shift is essential for macrophage and RGC differentiation.
Contribution of glycolysis to RGC differentiation
Our analyses revealed a mitophagy-dependent metabolic shift
towards glycolysis in the developing retina during the developmen-
tal stages studied. We next sought to determine whether this meta-
bolic shift was required for RGC differentiation. We blocked
glycolysis using 2-deoxyglucose (2DG) or 3-(3-pyridinyl)-1-(4-pyri-
dinyl)-2-propen-1-one (3-PO), which inhibit hexokinase and
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, respectively.
Inhibition of glycolysis decreased the number of differentiated RGCs
in the central and more mature area of the retina at E15.5 (E15.5M),
but had no effect on RGCs at E13.5 or on RGCs located in the
peripheral retina at E15.5 (E15.5Y; Fig 7A and B, and Appendix Fig
S1). This decrease in neuronal differentiation was not due to
increased cell death after glycolysis inhibition, as no increase in cell
death (as determined by TUNEL) was observed after the different
treatments (Fig EV5A and B), and caspase inhibition did not alter
RGC differentiation at E15.5 (Fig 7C). By contrast, blocking the
entry of pyruvate into the mitochondria with UK5099, a strategy
shown to increase glycolysis (Zhong et al, 2015), resulted in
increased RGC number and neither 3-MA nor CsA had any effect on
cell differentiation under these conditions (Fig 7D and E). Interest-
ingly, increased glycolysis did not alter mitochondrial number, indi-
cating that the metabolic change essential for cell differentiation
occurs downstream of mitophagy (Fig 7D and E).
Finally, to investigate the role of autophagy and mitophagy in
the maturation of RGCs at later developmental stages, we cultured
E18.5 retinas in the presence of CsA or 3-MA. No changes in RGC
numbers were observed (Figs 7F and EV5C). By contrast, the inhibi-
tion of glycolysis reduced RGC numbers at E18.5 (Figs 7G and
EV5D). Together these data confirm the involvement of glycolysis in
RGC maturation. Again, our data suggest that mitophagy precedes
the metabolic switch, as RGC maturation was unaffected by the
inhibition of autophagy or mitophagy in the mature region at E15.5
(Figs 7H and EV5E). These findings demonstrate that autophagy-
dependent mitochondrial degradation induces a metabolic shift
essential for cell differentiation.
Discussion
Here, we demonstrate that mitochondrial degradation via
programmed mitophagy induces a metabolic shift towards glycolysis
that is essential for cell differentiation. Specifically, this mitophagy-
dependent metabolic reprogramming is required for the correct
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Figure 6. NIX regulates mitophagy during retinal development.
A qPCR measurement of BNIP3L/NIX mRNA expression in mouse retinas at indicated developmental stages (n = 2–3 pools of retinas per embryonic stage). Data are
presented as mean  SEM.
B, C TOMM20 immunostaining (B) and corresponding quantification (C) (n = 4–8 retinas per group) in retinal flatmounts from wild-type and NIX-deficient mice at
E15.5. Scale bar, 10 lm. Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney U-test).
D Immunostaining for TOMM20 (red) in retinal sections from E15.5 wild-type and NIX-deficient mice. DAPI-stained nuclei are shown in blue. NbL, neuroblast layer;
RGCL, retinal ganglion cell layer. Scale bar, 75 lm.
E mRNA expression of the indicated genes in E15.5 wild-type (NIX+/+) and NIX-deficient (NIX/) mouse retinas (n = 5–8 pools of two retinas per group). Data are
presented as mean  SEM. *P < 0.05, **P < 0.01 (Mann-Whitney U-test).
F mRNA expression of Pou4f1 (Brn3a) in E15.5 wild-type (NIX+/+) and NIX-deficient (NIX/) retinas (n = 5–8 pools of two retinas per group). Data are presented as
mean  SEM. *P < 0.05 (Student’s t-test).
G Assessment of RGC differentiation by Brn3a immunostaining in retinal flatmounts from E15.5 wild-type (NIX+/+) and NIX-deficient (NIX/) mice. Scale bar, 50 lm.
H b-III-tubulin immunostaining (green) in retinal sections from E15.5 wild-type and NIX/-deficient mice. DAPI-stained nuclei are shown in blue. NbL, neuroblast
layer; RGCL, retinal ganglion cell layer. Scale bar, 75 lm.
I Brn3a (red) and c-synuclein (green) staining in retinal sections from E15.5 wild-type and NIX-deficient mice. Scale bar, 50 lm.
J Quantification of RGC number after Brn3a immunostaining in the RGC layer in eye sections from E15.5 wild-type (NIX+/+) and NIX-deficient (NIX/) mice (n = 4
eyes per group). Data are presented as mean  SEM (Mann-Whitney U-test).
K Quantification of RGC number after c-synuclein immunostaining in the RGC layer in eye sections from E15.5 wild-type (NIX+/+) and NIX-deficient (NIX/) mice
(n = 4 eyes per group). Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney U-test).
L Immunostaining of the RGCL for TOMM20 (red), c-synuclein (green) and DAPI (blue) in retinal sections from adult wild-type and NIX-deficient mice.
M Quantification of RGC number after Brn3a immunostaining in the RGC layer in eye sections from adult wild-type (NIX+/+) and NIX-deficient (NIX/) mice (n = 3
eyes per group). Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney U-test).
N Quantification of RGC number after c-synuclein immunostaining in the RGC layer in eye sections from adult wild-type (NIX+/+) and NIX-deficient (NIX/) mice
(n = 3 eyes per group). Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney U-test).
O qPCR measurement of BNIP3L/NIX mRNA expression in M1 and M2 macrophages (n = 6 per group). Data are presented as mean  SEM. *P < 0.05 (Mann-Whitney
U-test).
P, Q qPCR measurement of mRNA expression of glycolytic (P) and proinflammatory markers (Q) in M1 peritoneal macrophages from wild-type (NIX+/+) and NIX-deficient
(NIX/) mice (n = 6–8 per group). Data are presented as mean  SEM. **P < 0.01 (Mann-Whitney U-test).
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differentiation of RGCs, the first neurons generated in the vertebrate
retina, and for proinflammatory M1 macrophage polarization. In the
developing retina, mitophagy is regulated by hypoxia and the HIF-1
target gene BNIP3L/NIX, which triggers mitochondrial elimination
via autophagy resulting in a metabolic shift towards glycolysis
(Fig 8). We observed that neurogenesis was also attenuated in
autophagy-competent retinas following inhibition of glycolysis,
indicating that this increase in glycolysis is essential for cell differen-
tiation. Taken together, our findings demonstrate for the first time
that mitophagy regulates metabolic reprogramming towards glyco-
lysis during cell differentiation.
NIX transcription is usually maintained at low levels, but is
induced to mediate the elimination of mitochondria during reticulo-
cyte maturation (Diwan et al, 2007; Schweers et al, 2007; Sandoval
et al, 2008) and the generation of memory NK cells (O’Sullivan
et al, 2015). In the embryonic mouse retina, NIX levels peak shortly
after E15.5, while those of other known mitophagy regulators such
as PINK1 and Parkin increase postnatally (Fig EV5F). A similar
increase in NIX transcription is observed in M1 in comparison with
M2 macrophages, suggesting a pivotal role of NIX in programmed
mitophagy also during macrophage polarization. Several transcrip-
tion factors such as TFEB, SP1, FOXO3a, E2F1 and HIF-1 regulate
 Co0C  BOC
Brn3a
A
Brn3a
E15.5 ME15.5 YE13.5
Co
3-PO
2DG
*
*
* *
*
*
3-MA
10
Co CsA
0
2
4
6
8
E18.5 
 R
G
C
s(
x1
03
)/m
m
2  F
3-MACo CsA
E15.5 M
0
2
4
6
8
 R
G
C
s 
(x
10
3 )
/m
m
2  HG
2DGCo 3-PO
0
2
4
6
8
**
*
E18.5 
 R
G
C
s 
(x
10
3 )
/m
m
2  
*
B E15.5 ME15.5 Y
2DG
Co
3-PO
E13.5
*
2
4
6
8
 R
G
C
s 
(x
10
3 )
/m
m
2  
0 Co BOC
 R
G
C
s(
x1
03
)/m
m
2  
2
4
6
8
10
*
* *
Co UK UK+3-MAE
Brn3a
E15.5 M
2
4
6
8
 R
G
C
s 
(x
10
3 )
/m
m
2  Co
TO
M
M
20
 
(p
ix
el
sx
10
4 )
/m
m
2
0
2
4
6
8
10
0
UK
UK+3-MA
UK+CsA
D
* * *
* ***
Figure 7. Glycolysis regulates RGC differentiation.
A Brn3a immunostaining of RGCs in flat-mounted retinas corresponding to the indicated embryonic stages incubated with the glycolysis inhibitors 3-PO (10 lM) or
2DG (10 mM). Scale bar, 50 lm.
B Quantification of the number of RGCs in E13.5 and E15.5 retinas incubated as in (A) (n = 3–12 retinas per group). Data are presented as mean  SEM. *P < 0.05
(Mann-Whitney U-test).
C Caspase inhibition does not influence RGC differentiation as determined by Brn3a immunostaining of RGCs in flat-mounted E15.5 retinas treated with the pan-
caspase inhibitor Bob-D-FMK. Scale bar, 50 lm (n = 4 retinas per group). Data are presented as mean  SEM (Mann-Whitney U-test).
D Quantification of RGC number and TOMM20 immunostaining in E15.5 retinas treated with 40 lM of UK5099 in the absence or presence of CsA or 3-MA (n = 6–10
retinas per group). Data are presented as mean  SEM. *P < 0.05, ***P < 0.001 (Mann-Whitney U-test).
E Brn3a immunostaining of RGCs in flat-mounted retinas corresponding to E15.5 retinas incubated with UK in absence or presence of 3-MA. Scale bar, 50 lm.
F, G Quantification of RGC number in E18.5 retinas treated with CsA or 3-MA (F) (n = 3–7 retinas per group) and with 3-PO or 2DG (G) (n = 6–12 retinas per group).
Data are presented as mean  SEM. *P < 0.05, **P < 0.01 (Mann-Whitney U-test).
H Quantification of RGC number in E15.5 retinas treated with CsA and 3-MA (n = 9–12 retinas per group). Data are presented as mean  SEM (Mann-Whitney
U-test).
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NIX transcription (Hamacher-Brady & Brady, 2016). HIF-1 regulates
the expression of NIX in several cancer cell types, tumour-associated
macrophages and endothelial cells (Sowter et al, 2001; Ney, 2015).
The accumulation of several HIF-1-regulated transcripts and the
increased number of pimonidazole adducts observed during RGC
differentiation suggests that a hypoxia-like response may regulate
programmed mitophagy during retinal development. In agreement
with this view, increased HIF-1a staining has been observed in the
embryonic retina (Kurihara et al, 2010). In addition, we found that
artificial induction of chemical hypoxia in E15.5 retinas increased
NIX mRNA expression, reduced mitochondrial mass and increased
neuronal differentiation. All these effects were attenuated when
autophagy or mitophagy was blocked. While tissue hypoxia is a
classical trigger for M1 macrophage polarization during inflamma-
tion, LPS and other proinflammatory stimuli have been shown to
induce hypoxia-independent HIF-1 regulation (Escribese et al,
2012). Based on these findings, it is tempting to speculate that a
HIF-1-dependent pathway acts as a trigger for NIX-dependent meta-
bolic reprogramming during the macrophage polarization and
neuronal differentiation.
Beginning at E15.5, we observed a glycolytic switch in the retina,
as indicated by the accumulation of glycerol-3-phosphate and
lactate, as well as increased transcription of several glycolytic
enzymes. Supporting the view that anaerobic glycolysis is upregu-
lated during embryonic retina development, lactate dehydrogenase
levels were also increased (Fig EV5G). This switch to a glycolytic
profile was transient and was reversed at birth; levels of lactate, as
well as mRNA expression of many glycolytic enzymes, began to
decrease at birth (postnatal day 0, P0). Furthermore, this shift
was mitophagy dependent; lactate accumulation was attenuated in
Atg5-deficient retinas, and both 3-MA and CsA reduced lactate
production and decreased the expression of glycolytic enzymes.
These data corroborate our previous findings demonstrating that the
regulation of mitochondrial mass by mitophagy can mediate meta-
bolic reprogramming towards glycolysis in cancer cell lines
(Domenech et al, 2015).
While previous results by our group and others have demon-
strated the key role of autophagy in neuronal differentiation
(Vazquez et al, 2012; Wang et al, 2013), the present study demon-
strates for the first time that mitophagy is also essential for this
process. NIX- and Atg5-deficient mice displayed reduced numbers of
differentiated RGCs during retinal development. Furthermore, acti-
vation of autophagy using the mTOR inhibitor rapamycin induced
mitophagy and increased neuronal differentiation, an effect that was
blocked by 3-MA and CsA. Inhibition of glycolysis interfered with
RGC differentiation, indicating that the mitophagy-dependent
metabolic shift is essential for RGC maturation. Interestingly, this
effect occurred at E15.5 and at E18.5, while inhibition of autophagy
or mitophagy only reduced RGC numbers at earlier developmental
stages—where hypoxia takes place—in line with the view that
hypoxia-mediated mitophagy occurs upstream of the metabolic shift
towards glycolysis.
The importance of metabolic regulation for stem cell function
has been well described, and as a general rule stem cells predomi-
nantly rely on glycolytic metabolism (Chandel et al, 2016). On the
other hand, the differentiation of most cell types is typically
UK5099
NIX-/-
Atg5-/- 3-MA
CsA
Rapamycin
Figure 8. Working model.
During embryonic retinal development, proliferating neuroblasts display an increase in mitochondrial number and rely on oxidative phosphorylation for ATP production,
while recently differentiated retinal ganglion cells (RGCs) rely more on glycolysis and contain fewer mitochondria. The metabolic shift from the former profile to the latter is
regulated by a hypoxia-like response, which results in an increase in BNIP3L/NIX-dependentmitophagy. This in turn decreases mitochondrial number, increases glycolysis and
promotes RGC differentiation. Inhibition of autophagy (in Atg5-deficient mice or following 3-MA treatment), mitophagy (in NIX/ retinas or following CsA treatment) or
glycolysis (using the glycolysis inhibitor 2-deoxyglucose (2DG) or the Pfkfb3 inhibitor 3PO) impairs neuronal differentiation (red boxes). Conversely, RGC differentiation is
enhanced (green boxes) in response to deferoxamine mesylate (DFO)-induced chemical hypoxia, mTOR inhibition with rapamycin, and after augmenting glycolysis with
UK5099.
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associated with increased mitochondrial activity (Agathocleous
et al, 2012; Wagatsuma & Sakuma, 2013; Agostini et al, 2016; Cedi-
kova et al, 2016; Ellen Kreipke et al, 2016). However, in agreement
with our observations in RGCs, this view has been recently chal-
lenged (Forni et al, 2016). A decrease in mitochondrial activity and
increased mitophagy are observed during the differentiation of
mouse skin mesenchymal stem cells into chondrocytes (Forni et al,
2016). While those authors did not manipulate autophagy/mito-
phagy, they did show that manipulation of mitochondrial dynamic
could abrogate the metabolic shift and cell differentiation. Interest-
ingly, chondrocyte differentiation is also regulated by hypoxia
(Araldi & Schipani, 2010). These observations suggest that in
hypoxic conditions, as found in the embryonic retina and in the
foetal growth plate during bone formation, mitophagy-dependent
metabolic reprogramming may regulate cell differentiation.
The large numbers of mitochondria found in adult RGCs
(Appendix Fig S7A) suggest that mitochondrial biogenesis is
increased in these cells during the postnatal period, as cell metabo-
lism shifts to a more oxidative profile (Lathrop & Steketee, 2013; Yu
et al, 2013). Furthermore, mitophagy coupled to extensive mito-
chondrial biogenesis could constitute a mechanism by which
substrate preference is changed in order to sustain oxidative meta-
bolism, as recently described during perinatal maturation of the
mouse heart (Gong et al, 2015). However, the adult retina is depen-
dent on aerobic glycolysis, as already observed by Warburg (1956)
and recently reviewed by Ng et al (2015). This dependency is asso-
ciated with the high metabolic demands of photoreceptor cells, the
predominant cell type in the adult retina. Photoreceptors resemble
rapidly proliferating cells in that they lose and regenerate almost
10% of their outer segment each day during disc shedding. Thus,
glycolytic metabolism is implicated in two phases of retinal develop-
ment: during embryonic development, as demonstrated in the
present study, and in the mature retina, as previously described
(Warburg, 1956; Appendix Fig S7B and C).
Here, we demonstrate the generality of our findings in a second
paradigm associated with metabolic reprogramming. During polar-
ization, M1 macrophages shift their metabolism towards glycolysis
to fuel the metabolic demands imposed by inflammatory responses
(O’Neill & Pearce, 2016). We found that blockade of autophagy and
mitophagy during M1 macrophage polarization resulted in an
increase in mitochondrial mass, and reduced expression of glyco-
lytic genes and M1-associated proinflammatory cytokines. This
effect was also observed in NIX-deficient macrophages. Interest-
ingly, this decrease in M1 polarization did not result in increased
M2 responses in NIX-deficient macrophages, suggesting that mito-
phagy controls M1 responses. Moreover, our data indicate that a
decreased M1 phenotype does not result in increased M2 phenotype,
in agreement with recent evidence (Van den Bossche et al, 2016). In
line with previous findings linking rapamycin treatment with
increased M1 polarization (Mercalli et al, 2013), we observed an
increase in RGC differentiation during retinal in response to this
autophagy/mitophagy inducer. Together with the observed arrest of
M1 macrophage polarization in response to blockade of autophagy
and mitophagy, our data indicate that a cell differentiation pathway
involving mitophagy and glycolysis is active in several cellular
contexts.
Why is the mitochondrial mass of RGCs transiently reduced
during differentiation? One possible explanation for this metabolic
switch is the increased anabolic requirements of these neurons,
which at this stage begin to generate long axons to connect the
retina to the brain. In support of this hypothesis, we detected
profound defects in axon morphology in autophagy-deficient reti-
nas. Moreover, we observed an accumulation of TCA intermedi-
ates including succinate, fumarate and malate in wild-type mouse
retinas between E15.5 and P0 (Fig EV5H). Interestingly, these
metabolites also accumulate in M1 macrophages, a phenomenon
known as the “broken” TCA cycle, and may actually trigger the
inflammatory response (Jha et al, 2015; O’Neill, 2015). It is thus
plausible that programmed mitophagy is essential to promote this
metabolic reprogramming towards glycolysis to fulfil the anabolic
requirements for neuronal differentiation and M1 macrophage
polarization. Supporting this hypothesis, glycolysis and activity of
the pentose phosphate pathway have been observed during the
early stages of in vitro differentiation of cortical neurons (Agostini
et al, 2016). The transient increase in glycolysis observed in the
embryonic retina thus indicates a special mitophagy-dependent
metabolic requirement during the early stages of RGC differentia-
tion. Alternatively, mitophagy may constitute a drastic mitochon-
drial quality control mechanism, which eliminates damaged
organelles that would otherwise act as a potentially deleterious
source of ROS in these long-lived, postmitotic cells. Near-perfect
mitochondrial function is indeed critical for vision, as evidenced
by the close association between blindness and mitochondri-
opathies (Schrier & Falk, 2011), and the mitochondrial damage
that underlies several disease conditions involving RGC dysfunc-
tion (e.g. glaucoma; Chrysostomou et al, 2013).
Taken together, our data demonstrate that programmed mito-
phagy is essential for metabolic reprogramming towards glycolysis
associated with cell differentiation. More importantly, we demon-
strate that neurogenesis during mammalian neuronal differentiation
is dependent on a marked increase in mitophagy.
Materials and Methods
Animal procedures
All animal procedures and study protocols were approved by the
local ethics committee for animal experimentation and the ethics
committees of the CSIC and the Albert Einstein College of Medicine
and were carried out in accordance with US and EU regulations and
the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. Wild-type C57BL/6J and CD1 mice were obtained
from The Jackson Laboratory (Bar Harbor, ME, USA). Atg5 mice
(Kuma et al, 2004) were kindly provided by Prof. Noboru
Mizushima (Department of Biochemistry and Molecular Biology,
Graduate School and Faculty of Medicine, The University of Tokyo).
NIX/BNIP3L mice (Diwan et al, 2007) were kindly provided by
Prof. Gerald W. Dorn, II, Washington University in St. Louis). Both
male and female animals were used in this study. Mice were reared
in a barrier-controlled facility (20°C; 12-h light/dark cycle) with
ad libitum access to food and water. Animals were crossed and the
morning on which the vaginal plug was detected was designated
embryonic day (E) 0.5. Animals were euthanized by cervical
dislocation and embryos removed by caesarean section.
The embryos were staged and then placed in a Petri dish in
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1× phosphate-buffered saline (PBS). Eyes were removed under a
dissecting microscope and fixed for 1 h in 4% PFA. Alternatively,
neuroretinas were dissected by separating the pigment epithelium,
lens, vitreous body, vessels and other tissues. For hypoxia staining,
we used the Hypoxyprobe kit (Cat. # HP3-100kit). Pimonidazole at
60 mg/kg body weight was injected intraperitoneally. Three hours
later, mice were euthanized by cervical dislocation and embryos
removed by caesarean section.
Organotypic retinal cultures
Neuroretinas were cultured for 6 h in DMEM:HAM/F12 (42400,
Gibco) supplemented with 10 mM sodium bicarbonate (S7561),
1.1 mg/l pyruvate (P2256), 100 mg/l apotransferrin (T2252),
0.02 mg/ml sodium selenite (S5261), 0.32 mg/l putrescine (P5780),
0.2 mg/l progesterone (P8783), all from Sigma, and 0.05 g/l
gentamicin (15710, Gibco), and pH set to 7.14. Before conducting
experiments, the medium was supplemented with 2 mM glutamine
(25030, Gibco) and 10 nM recombinant human insulin (I2643,
Sigma). Retinas were treated by adding the following compounds to
the medium, as indicated: 10 mM 3-methyladenine (3-MA; M9281,
Sigma), 200 nM rapamycin (R-5000, Euromedex), 5 lM CsA
(30024, Sigma), 10 mM 2DG (D8375, Sigma), 10 lM 3-PO (525330,
Millipore), 40 lM UK5099 (PZ0160) 1 mM DFO (D9533, Sigma),
15 lg/ml hydroxychloroquine (HCQ; 880872.4, Laboratorios Rubio´
S.A.) and 25 lM Boc-D-FMK (218575, Calbiochem). After culture,
the retinas were washed twice with PBS and analysed as described
below.
Flow cytometry
After isolation of culture, retinas were incubated for 5 min at 37°C
in 0.5 mg/ml trypsin (3703, Worthington) in HBSS (14170-088,
Gibco) and then dissociated by gentle pipetting. Trypsin-mediated
digestion was arrested by the addition of foetal bovine serum, and
cells were centrifuged at 290 g and resuspended in HBSS (14170-
088, Gibco). Cells were then incubated with 10 nM MitoTracker
Deep Red (M22426, Invitrogen) or 40 nM DiOC6(3) (D273). Next,
10,000 cells were acquired in the FL4 and FL1 channels of an FC500
flow cytometer (Beckman Coulter), and the mean fluorescence
intensity (MFI) of the viable cell population (determined in FSC and
SSC channels) was analysed and normalized against that of
untreated cells (Esteban-Martinez et al, 2017).
Immunofluorescence staining of flat-mounted retinas or
cryosections and confocal microscopy analysis
Fixed eyes were cryopreserved in 15% sucrose in 1× PBS overnight,
followed by 30% sucrose for 1 week. Eyes were embedded in
Tissue-Tek OCT (Sakura Finetechnical Co. Ltd., Tokyo, Japan) and
sectioned at 12 lm on a LEICA CM 1950 cryostat. The sections were
then fixed for 15 min with 4% PFA, blocked with BGT (BSA,
glycine, Triton), permeated with 1% (w/v) Triton X-100 and
incubated overnight with selected antibodies as described below.
Alternatively, freshly dissected or cultured retinas were flat-
mounted onto nitrocellulose membranes, fixed overnight in 4%
paraformaldehyde (w/v) in 0.1 M phosphate buffer (pH 7.4) and
then permeated with 1% (w/v) Triton X-100. The retinas or
cryosections were subsequently incubated overnight at 4°C with
primary antibodies raised against the following antigens: TOMM20
(sc-11415, Santa Cruz), COXIV (459600, Invitrogen), Brn3a
(MAB1585, Millipore), b-III-tubulin (MMS-435P, COVANCE),
GLUT1 (AB400084, Abcam) and PAb2627AP (HP3-100 kit, Hypoxy-
probe). The c-synuclein antibody (Nguyen et al, 2011) was kindly
provided by Prof. Marsh-Armstrong (University of California at
Davis). Next, samples were incubated with Alexa secondary anti-
bodies (Invitrogen) diluted at 1:200 in 10% NGS in PBS. Nuclei
were labelled with 1 lg/ml DAPI (D9542, Sigma), and samples were
mounted with DABCO (D27802, Sigma). When necessary, the signal
was amplified using fluorochrome-conjugated streptavidin with the
TSA System (SAT704A001EA, PerkinElmer). Confocal analysis was
performed with an SP5 Leica confocal microscope. The interval
between confocal planes was 1 lm for eye sections and 2 lm for
flat-mounted retinas. If not stated otherwise, maximum projections
of the all z-stacks are displayed. The TOMM20-positive area was
automatically quantified in ImageJ. The macro was created by trans-
forming the maximum projections in the RGC layer into 16-bit
images, and a minimum detection threshold common to all images
was set to define positive staining. The number of positive pixels
was quantified automatically and expressed as number of pixels per
104/mm2. Quantification of RGCs was performed by counting the
total number of Brn3a-positive nuclei in the maximum projections
of flat-mounted retinas. TUNEL staining was performed as described
previously (Melle´n et al, 2009).
Immunoblotting
Retinas were maintained at 80°C until processing. Proteins were
extracted from at least three pooled retinas in lysis buffer consisting
of 50 mM Tris–HCl (pH 6.8), 10% glycerol (v/v), 2% SDS (w/v),
protease inhibitor cocktail (P8783) and phosphatase inhibitors
(1 mM sodium orthovanadate (S6508), 1 mM sodium fluoride
(201154) and 5 mM sodium pyrophosphate (221368), all from
Sigma. Retinas were homogenized using a plastic pestle until
completely disaggregated. Next, samples were heated for 10 min at
95°C and stored at 20°C. Protein concentration was determined
using the Pierce BCA Protein Assay Kit (23227, Pierce Thermo
Fisher Scientific) and measured at 540 nm. Total protein extract
(15 lg) was mixed with 10 mM DTT and bromophenol blue, loaded
into Any kD Criterion TGX Precast Gels (567–1124, Bio-Rad) and
transferred onto PVDF membranes (170–4157, Bio-Rad) for 14 min
at 25 V using a Trans-Blot Turbo Transfer System (Bio-Rad). After
transfer, membranes were activated with 100% methanol for 2 min
and blocked for 1 h at room temperature with 5% non-fat milk in
PBS-T (1× PBS, 0.5% Tween 20 (v/v)). The membranes were subse-
quently incubated with primary antibodies anti-LC3 (L7543, Sigma),
PCNA, (Delta Biolabs C19), GAPDH (Ab8245, Abcam), TIMM23 (BD
611222), a-tubulin (sc-8035, Santa Cruz), b-actin (A5441, Sigma),
TOMM20 (sc-11415), COX-IV (459600, Invitrogen) and PFKFB3
(131238, Cell Signaling).
Metabolic determinations
For mass spectrometry, 20 mg of retinal tissue was used obtained
from pools of 28 retinas from E12.5, 35 retinas from E13.5, 24 reti-
nas from E15.5, 24 retinas from E18.5, 24 retinas from P0 and
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four retinas from P9 and P15 per developmental stage. The tissue
was first weighted for each condition and then solubilized with
500 ll of cold (20°C) lysate buffer (MeOH/water/chloroform,
9/1/1, 20°C with internal standards) in 1.5 ml polypropylene
Precellys lysis tubes). They were then homogenized three times
for 20 s using Precellys 24 tissue homogenizer (Bertin Technolo-
gies), followed by centrifugation (10 min at 15,000 × g and 4°C).
The upper phase of the supernatant was collected. Another extrac-
tion of 500 ll of lysate buffer, followed by another homogeniza-
tion, was next performed. After centrifugation, the supernatant
was collected and added to the first extraction. The supernatant
was then evaporated in microcentrifuge tubes at 40°C in a pneu-
matically assisted concentrator (Techne DB3, Staffordshire, UK).
Methanol (300 ll) was added to the dried extract and split into
two parts of 150 ll: the first was used for the GC-MS experiment
and the second for LC-MS determinations. The GC-MS aliquots
were solubilized in methanol and transferred to a glass tube and
evaporated again. Fifty microlitres of methoxyamine (20 mg/ml in
pyridine) was added to the dried extracts, which were then stored
at room temperature in darkness for 16 h. The following day,
80 ll of MSTFA was added and final derivatization performed at
40°C for 30 min. Samples were then transferred to glass vials and
directly injected into GC-MS. After the second evaporation of the
LC-MS aliquots, the LC-MS-dried extracts were solubilized with
50 ll of MilliQ water, centrifuged (10 min at 15,000 × g and 4°C),
transferred to glass vials and directly injected into UHPLC/MS.
Target analysis was performed as previously described (Enot et al,
2015). After manual verifications and QC protocols, 83 metabolites
were selected for GC targeted analysis and 17 metabolites for LC
targeted analysis. Real-time analysis of the extracellular acidifi-
cation rate (ECAR) and oxygen consumption rate (OCR) was
performed using a Seahorse XF-24 metabolic extracellular flux
analyser (Seahorse Bioscience). After dissection, neuroretinas were
flat-mounted onto nitrocellulose membranes and resuspended in
XF assay medium (DMEM/F12, D0547, Sigma) and assessed in a
Seahorse XF24 islet capture microplate. Values were normalized
per lg of protein.
qPCR and RNA sequencing
RNA was extracted from 2 to 3 pools of six retinas (E12.5–E18.5) and
of three retinas at P0. For qPCR, 5 to 6 pools of two retinas were used
for ex vivo experiments and three pools of two retinas for the experi-
ments with the Atg5/ and the NIX/ mice. Total RNA from reti-
nas was extracted using TRIzol reagent, and reverse transcription
performed using the High-Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Waltham, MA, USA) according to the manufac-
turer’s instructions. Quantitative real-time PCR was performed in a
Light Cycler 480 Instrument (Roche, Mannheim, Germany) with
Taqman Universal PCR Master Mix using Taqman assays (Life Tech-
nologies, Carlsbad, CA, USA). The following probes were used:
Ppargc1a, Mm01208835_m1; Tfam, Mm00447485_m1; Pfkfb3,
Mm00504650_m1; Hk2, Mm00443385_m1; Pkm2, Mm00834102_gH;
Gapdh, Mm99999915_g1; Pink1, Mm00550827_m1; Parkin, Mm00
450187_m1; Optineurin, Mm01333245_m1; Fundc1, Mm005111
32_m1; Bnip3L/Nix, Mm00786306; Pou4f1, Mm02343791; Il1b,
Mm00434228_m1; Nos2, Mm00440502_m1; Tnf, Mm00443258_m1;
Igf1, Mm00439560; Arginase1, Mm00475988; Mannose receptor,
Mm00485148; 18S, Hs99999901_s1. Assays were performed in dupli-
cate, and results were normalized according to expression levels of
18S RNA. Results are expressed using the 2DDCT (cycle threshold)
quantification method.
Transcriptomic data have been deposited in the GEO repository
(accession number GSE84299). Total RNA was extracted from a
pool of 24 retinas per developmental stage. Total RNA (1 lg) with
RIN (RNA integrity number) numbers ranging from 8.6 to 9.9
(Agilent 2100 Bioanalyzer) was used. PolyA+ fractions were
processed using the TruSeq Stranded mRNA Sample Preparation kit
(Agilent). The resulting directional cDNA libraries were sequenced
for 50 bases in a single-read format (IlluminaHiSeq 2000) and anal-
ysed with Nextpresso, a computational pipeline that performs a
complete automated analysis using state-of-the-art tools. Nextpresso
works as follows: reads are quality-checked with FastQC (http://
www.bioinformatics.babraham.ac.uk/projects/fastqc/) and aligned
to the mouse genome (GRCm38/mm10) with TopHat-2.0.10
(Trapnell et al, 2012), using Bowtie 1.0.0 and Samtools 0.1.19,
allowing two mismatches and five multihits (Langmead et al, 2009;
Li et al, 2009). Transcript assembly and the estimation of abun-
dance and differential expression are determined with Cufflinks
2.2.1 (Trapnell et al, 2012), using the mouse genome annotation
data set GRCm38/mm10 from the UCSC Genome Browser (Speir
et al, 2016). Heatmap figures were subsequently generated with
GENE-E (http://www.broadinstitute.org/cancer/software/GENE-E/
index.html). Hypoxia-regulated genes were selected from
HypoxiaDB as previously described (Khurana et al, 2013).
Primary macrophage isolation and activation
Adult CD1 or NIX mice were intraperitoneally injected with 1 ml of
4% (w/v) thioglycolate broth to elicit peritoneal macrophages
(Rodriguez-Prados et al, 2010). After 4 days, the animals were euth-
anized and intraperitoneally injected with 10 ml of cold sterile PBS,
followed by aspiration and peritoneal lavage. Peritoneal macro-
phages were washed twice with 10 ml cold PBS, counted and resus-
pended at a concentration of 0.5 × 106 cells/ml in complete RPMI
1640 medium supplemented with 10% FBS with antibiotics. Next,
0.5 × 106 cells or 1 × 106 cells were cultured for 24 h in 24- and
12-well plates for flow cytometry and RNA isolation, respectively, in
the presence of LPS (100 lg/ml, E. coli 055:B5, Sigma-Aldrich) and
mIFN-c (20 lg/ml, Immunotools, Germany) or with mIL-4+ mIL-13
(20 lg/ml, Immunotools). Cells were subsequently cultured for 6 h
with 10 mM 3-MA and 5 lM CsA and then analysed by microscopy
or trypsinized for mRNA extraction or flow cytometry assessment.
Transmission electron microscopy
Retinas were fixed for 4 h at 4°C in Karnovsky buffer (4%
paraformaldehyde (w/v) and 2.5% glutaraldehyde (v/v) in cacody-
late buffer (Sigma), pH 7.4), washed and fixed again in aqueous
5% (w/v) osmium tetroxide, 1% potassium ferricyanide. Next, the
retinas were dehydrated and immersed in propylene oxide for
3 × 10 min and embedded in Epon resin (EMS). The resin was
polymerized at 50°C overnight. An ultramicrotome (Vitracut E,
Reichert-Jung) was used to cut ultra-thin sections (50 nm) for elec-
tron microscopy analysis. Sections were stained with uranyl
acetate and lead citrate and analysed using a Zeiss EM 902
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transmission electron microscope (Germany), set at 90 kV. Mito-
chondrial number was quantified in ImageJ by analysing at least
14 different images per retinal region (retinal ganglion cell layer
and neuroblast layer).
Statistical analyses
Data are presented as the mean  the standard error of the mean of
at least three independent experiments performed in triplicate. Dif-
ferences between treatments were analysed using a Student’s t-test,
ANOVA or in the case of non-normally distributed data, a nonpara-
metric Mann–Whitney U-test (SPSS 17.0). Statistical significance
was set at P < 0.05. *P < 0.05, **P < 0.01, ***P < 0.001.
Expanded View for this article is available online.
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